HOW GOOD ELDERLY RHEUMATOID ARTHRITIS PATIENTS RESPOND AT FIRST YEAR OF TREATMENT WITH CERTOLIZUMAB PEGOL?

被引：0
|
作者：
Torrente-Segarra, V. [1 ]
Prada, M. Fernandez [2 ]
Exposito, R. [3 ]
Punal, N. Garrido [4 ]
Sanchez-Andrade, A. [5 ]
Lamua-Riazuelo, J. R. [6 ]
Olive, A. [7 ]
Tovar, J. V. [8 ]
机构：
[1] Hosp Gen Hospitalet Moises Bragg, Rheumatol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Guadalajara, Guadalajara, Spain
[3] Hosp Comarcal Laredo, Laredo, Spain
[4] Hosp Univ Virgen Rocio, Seville, Spain
[5] Complejo Hosp Univ Lucus Augusti, Alicante, Spain
[6] Hosp Univ Henares, Alcala De Henares, Spain
[7] Hosp Germans Tries & Pujol, Badalona, Spain
[8] Hosp Gen Univ Elche, Elche, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.1727
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0208
引用
收藏
页码：964 / 965
页数：2
相关论文
共 50 条
  • [21] Certolizumab pegol: a new biologic targeting rheumatoid arthritis
    Patel, Aarat M.
    Moreland, Larry W.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) : 855 - 866
  • [22] The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
    Fleischmann, Roy
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (05) : 773 - 786
  • [23] Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis
    Domanska, Barbara
    VanLunen, Brenda
    Peterson, Luke
    Mountian, Irina
    Schiff, Michael
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (01) : 15 - 22
  • [24] Certolizumab pegol with methotrexate improves performance at work in patients with active rheumatoid arthritis
    Smolen, Josef
    Emery, Paul
    Kavanaugh, Arthur
    Richard, Lance
    Purcaru, Oana
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S527 - S528
  • [25] Safety Update on Certolizumab Pegol (CZP) in Patients with Active Rheumatoid Arthritis (RA)
    Van Vollenhoven, Ronald
    Smolen, Joseph
    Schiff, Michael
    Fleischmann, Roy
    Combe, Bernard
    Goel, Niti
    Desai, C.
    Curtis, Jeffrey
    Keystone, Edward
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1332 - 1332
  • [26] Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis
    Soriano, Enrique R.
    Dellepiane, Analia
    Salvatierra, Gabriela
    Alejandro Benitez, Cristian
    Garcia Salinas, Rodrigo
    Baruzzo, Carlos
    FUTURE SCIENCE OA, 2018, 4 (04):
  • [27] DECLINE IN HEALTHCARE RESOURCE CONSUMPTION FOR PATIENTS WITH RHEUMATOID ARTHRITIS STARTING CERTOLIZUMAB PEGOL
    Saraux, A.
    Flipo, R.
    Fagnani, F.
    Cukierman, G.
    Joubert, J.
    Schuller, J.
    Massol, J.
    Combe, B.
    VALUE IN HEALTH, 2018, 21 : S301 - S301
  • [28] Treatment strategies for patients with plaque psoriasis who respond inadequately to certolizumab pegol during the first 16 weeks of treatment
    Warren, R.
    Lebwohl, M.
    Piguet, V.
    Sofen, H.
    Blauvelt, A.
    Brock, F.
    Arendt, C.
    Boehnlein, M.
    Augustin, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 74 - 75
  • [29] Patients with Rheumatoid Arthritis Achieve a Rapid Response When Treated with Certolizumab Pegol Irrespective of Background Treatment
    Cividino, Alf
    Fleischmann, Roy
    Keystone, Edward
    Luijtens, Kristel
    Furst, Daniel E.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2568 - 2568
  • [30] Certolizumab Pegol with Methotrexate Improves Performance at Work in Patients with Active Rheumatoid Arthritis
    Russell, Anthony
    Smolen, Josef
    Emery, Paul
    Kavanaugh, Arthur
    Richard, Lance
    Purcaru, Oana
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2580 - 2580
12345